当前位置: 首页 >> 检索结果
共有 11036 条符合本次的查询结果, 用时 4.0681435 秒

721. Impact of Clinical Demands on the Educational Mission in Hospital Medicine at 17 Academic Medical Centers : A Qualitative Analysis.

作者: Vishruti Patel.;Angela Keniston.;Lauren McBeth.;Sagarika Arogyaswamy.;Catherine Callister.;Khooshbu Dayton.;Neelam Mistry.;Sarah Mann.;Marisha Burden.
来源: Ann Intern Med. 2023年176卷11期1526-1535页
Clinical growth is outpacing the growth of traditional educational opportunities at academic medical centers (AMCs).

722. SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.

作者: Gregory E Edelstein.;Julie Boucau.;Rockib Uddin.;Caitlin Marino.;May Y Liew.;Mamadou Barry.;Manish C Choudhary.;Rebecca F Gilbert.;Zahra Reynolds.;Yijia Li.;Dessie Tien.;Shruti Sagar.;Tammy D Vyas.;Yumeko Kawano.;Jeffrey A Sparks.;Sarah P Hammond.;Zachary Wallace.;Jatin M Vyas.;Amy K Barczak.;Jacob E Lemieux.;Jonathan Z Li.;Mark J Siedner.
来源: Ann Intern Med. 2023年176卷12期1577-1585页
Data are conflicting regarding an association between treatment of acute COVID-19 with nirmatrelvir-ritonavir (N-R) and virologic rebound (VR).

723. Relationship Between Clinician Language and the Success of Behavioral Weight Loss Interventions : A Mixed-Methods Cohort Study.

作者: Charlotte Albury.;Helena Webb.;Elizabeth Stokoe.;Sue Ziebland.;Constantinos Koshiaris.;Joseph J Lee.;Paul Aveyard.
来源: Ann Intern Med. 2023年176卷11期1437-1447页
International guidelines recommend that primary care clinicians recognize obesity and offer treatment opportunistically, but there is little evidence on how clinicians can discuss weight and offer treatment in ways that are well received and effective.

724. In ischemic LV dysfunction, adding PCI to medical therapy did not reduce a composite of death or aborted sudden death.

作者: Richard G Bach.
来源: Ann Intern Med. 2023年176卷11期JC122页
Perera D, Morgan HP, Ryan M, et al; REVIVED-BCIS2 Investigators. Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: prespecified analyses from the REVIVED-BCIS2 trial. Circulation. 2023;148:862-871. 37555345.

725. In adults with BMI ≥27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk.

作者: Mayer B Davidson.
来源: Ann Intern Med. 2023年176卷11期JC129页
Garvey WT, Frias JP, Jastreboff AM, et al; SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402:613-626. 37385275.

726. In RA, use of systemic glucocorticoids ≥5 mg/d (prednisolone-equivalent) was linked to MACE at 8.7 y.

作者: Ami Schattner.
来源: Ann Intern Med. 2023年176卷11期JC131页
So H, Lam TO, Meng H, et al. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2023;82:1387-1393.37487608.

727. In adults with HIV and low-to-moderate CV risk, pitavastatin reduced MACE over a median 5.1 y.

作者: Scott Selinger.
来源: Ann Intern Med. 2023年176卷11期JC130页
Grinspoon SK, Fitch KV, Zanni MV, et al; REPRIEVE Investigators. Pitavastatin to prevent cardiovascular disease in HIV infection. N Engl J Med. 2023;389:687-699. 37486775.

728. Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension : An Observational Study.

作者: Mitchell Tang.;Carter H Nakamoto.;Ariel D Stern.;Jose R Zubizarreta.;Felippe O Marcondes.;Lori Uscher-Pines.;Lee H Schwamm.;Ateev Mehrotra.
来源: Ann Intern Med. 2023年176卷11期1465-1475页
Remote patient monitoring (RPM) is a promising tool for improving chronic disease management. Use of RPM for hypertension monitoring is growing rapidly, raising concerns about increased spending. However, the effects of RPM are still unclear.

729. In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level.

作者: Rodolfo A Estrada.;Diego J Maselli.
来源: Ann Intern Med. 2023年176卷11期JC128页
Corren J, Menzies-Gow A, Chupp G, et al. Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials. Am J Respir Crit Care Med. 2023;208:13-24. 37015033.

730. In low-risk penicillin allergies, direct oral challenge was noninferior to skin testing followed by oral challenge.

作者: KoKo Aung.;Thwe Htay.
来源: Ann Intern Med. 2023年176卷11期JC127页
Copaescu AM, Vogrin S, James F, et al. Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized clinical trial. JAMA Intern Med. 2023;183:944-952. 37459086.

731. In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.

作者: Manasi Tannu.;L Kristin Newby.
来源: Ann Intern Med. 2023年176卷11期JC123页
Gragnano F, Cao D, Pirondini L, et al; PANTHER Collaboration. P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events. J Am Coll Cardiol. 2023;82:89-105. 37407118.

732. Personal Actions to Create a Culture of Inclusion: Navigating Difficult Conversations With Medical Colleagues.

作者: Melanie S Sulistio.;Christine L Chen.;Ijeoma Eleazu.;Sarah Godfrey.;Reeni A Abraham.;Lorrel E B Toft.
来源: Ann Intern Med. 2023年176卷11期1520-1525页
Microaggressions between members of a team occur often in medicine, even despite good intentions. Such situations call for difficult conversations that restore inclusivity, diversity, and a healthy work culture. These conversations are often hard because of the unique background, experiences, and biases of each person. In medicine, skillful navigation of these interactions is paramount as it influences patient care and the workplace culture. Although much has been published about difficult interactions between providers and patients, significantly less information is available to help navigate provider-to-provider interactions, despite their critical role in improving multidisciplinary patient care teams and organizational environments. This article is intended to serve as a guide for medical professionals who are interested in taking personal responsibility for promoting a safe and inclusive culture by engaging in and modeling difficult conversations with colleagues. The article outlines important considerations to assist with intentional preparation and modulation of responses for all parties involved: conversation initiators, observers of the incident, and conversation receivers. Although these interactions are challenging, together as medical professionals we can approach each other with humility and compassion to achieve our ultimate goal of promoting humanity, not only for our patients but for ourselves and one another.

733. Thiazides do not affect mortality but may reduce CV events vs. nondiuretic antihypertensive drugs at up to 5 y.

作者: Anuj A Patel.;David S Goldfarb.
来源: Ann Intern Med. 2023年176卷11期JC124页
Reinhart M, Puil L, Salzwedel DM, et al. First-line diuretics versus other classes of antihypertensive drugs for hypertension. Cochrane Database Syst Rev. 2023;7:CD008161. 37439548.

734. In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes.

作者: Katarzyna Nabrdalik.;Gregory Y H Lip.
来源: Ann Intern Med. 2023年176卷11期JC125页
Banerjee M, Pal R, Maisnam I, et al. Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: a meta-analysis and meta-regression of randomized controlled trials. Diabetes Obes Metab. 2023;25:2697-2703. 37334516.

735. The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug Administration.

作者: Patricia J Zettler.;Lewis A Grossman.;Eli Y Adashi.;I Glenn Cohen.
来源: Ann Intern Med. 2023年176卷12期1666-1669页
In August 2023, a federal appeals court issued an opinion in Alliance for Hippocratic Medicine v FDA, a case wherein a group of antiabortion medical organizations and physicians have challenged U.S. Food and Drug Administration (FDA) approval and regulation of mifepristone. This opinion contained some good news for the FDA, drug makers, and patients: the appeals court declined to halt the marketing of mifepristone altogether (as the trial court judge would have). But the court also decided that the FDA's 2016 and 2021 actions expanding the indication for mifepristone, lowering the drug's dose, and loosening restrictions on its distribution and use were likely unlawful, and it thus affirmed the trial court's order staying these actions. In this article, we explain key aspects of the opinion to health care professionals and consider the ways in which the appeals court's reasoning and conclusions, if followed by the Supreme Court, could undermine abortion access and public health going forward.

736. In healthy older adults, low-dose aspirin did not differ from placebo for ischemic stroke but increased intracranial bleeding.

作者: Salvador Cruz-Flores.
来源: Ann Intern Med. 2023年176卷11期JC126页
Cloud GC, Williamson JD, Thao LTP, et al. Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people: secondary analysis of a randomized clinical trial. JAMA Netw Open. 2023;6:e2325803. 37494038.

737. Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation.

作者: George N Ioannou.;Kristin Berry.;Nallakkandi Rajeevan.;Yuli Li.;Pradeep Mutalik.;Lei Yan.;David Bui.;Francesca Cunningham.;Denise M Hynes.;Mazhgan Rowneki.;Amy Bohnert.;Edward J Boyko.;Theodore J Iwashyna.;Matthew L Maciejewski.;Thomas F Osborne.;Elizabeth M Viglianti.;Mihaela Aslan.;Grant D Huang.;Kristina L Bajema.
来源: Ann Intern Med. 2023年176卷11期1486-1497页
COVID-19 has been linked to the development of many post-COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral antivirals used to treat acute COVID-19 in preventing the development of PCCs.

738. Effect of Complementary Interventions to Redesign Care on Teamwork and Quality for Hospitalized Medical Patients : A Pragmatic Controlled Trial.

作者: Kevin J O'Leary.;Julie K Johnson.;Mark V Williams.;Ronald Estrella.;Krystal Hanrahan.;Luci K Leykum.;G Randy Smith.;Jenna D Goldstein.;Jane S Kim.;Sara Thompson.;Iva Terwilliger.;Jing Song.;Jungwha Lee.;Milisa Manojlovich.
来源: Ann Intern Med. 2023年176卷11期1456-1464页
Multiple challenges impede interprofessional teamwork and the provision of high-quality care to hospitalized patients.

739. Clinical Effectiveness of Cognitively Enhanced Tai Ji Quan Training on Global Cognition and Dual-Task Performance During Walking in Older Adults With Mild Cognitive Impairment or Self-Reported Memory Concerns : A Randomized Controlled Trial.

作者: Fuzhong Li.;Peter Harmer.;Elizabeth Eckstrom.;Kathleen Fitzgerald.;Kerri Winters-Stone.
来源: Ann Intern Med. 2023年176卷11期1498-1507页
Mild cognitive impairment (MCI) negatively impacts cognition and dual-task abilities. A physical-cognitive integrated treatment approach could mitigate this risk for dementia.

740. Health as a Human Right: A Position Paper From the American College of Physicians.

作者: Matthew DeCamp.;Lois Snyder Sulmasy.; .
来源: Ann Intern Med. 2023年176卷11期1516-1519页
The relationship of health to rights or human rights is complex. Although many find no right of any kind to health or health care, and others view health care as a right or human right, the American College of Physicians (ACP) instead sees health as a human right. The College, in the ACP Ethics Manual, has long noted the interrelated nature of health and human rights. Health as a human right also has implications for the social and structural determinants of health, including health care. Any rights framework is imperfect, and rights, human rights, and ethical obligations are not synonymous. Individual physicians and the profession have ethical obligations to patients, and these obligations can go beyond matters of rights. Society, too, has responsibilities-the equitable and universal access to appropriate health care is an ethical obligation of a just society. By recognizing health as a human right based in the intrinsic dignity and equality of all patients and supporting the patient-physician relationship and health systems that promote equitable access to appropriate health care, the United States can move closer to respecting, protecting, and fulfilling for all the opportunity for health.
共有 11036 条符合本次的查询结果, 用时 4.0681435 秒